BlueSemi to showcase EYVA at VivaTech, Europe’s annual innovation, startup & tech event

The company will display its flagship product EYVA, the world’s first non-invasive gadget that can measure 6 key body vitals, at the Indian Pavilion at VivaTech as part of its exclusive European debut

0
117
New Delhi: BlueSemi, India’s leading Healthtech company, will be representing India at VivaTech Expo,  Europe’s biggest annual innovation, start-up, and tech event to be held from June 15th- 18th 2022 in Paris, France.
BlueSemi will be showcasing its marquee product, EYVA, the world’s first non-invasive gadget that can measure 6 key body vitals including Blood glucose, ECG, Heart rate, Blood Pressure, SPo2, HbA1C in less than 60 seconds with a single touch, at the Indian Pavilion at the event as part of its exclusive European debut.
The event will include an ensemble collection of start-up showcases, innovation exhibits, workshops, panel discussions, CEO talks, etc. from countries and MNCs across the world while enabling attendees from 149 countries, hear live talks from top speakers around the world
The occasion is extra special for India as for the first time ever, the country has been conferred the status of – Country of the Year. Hence, it is a matter of great pride and paramount importance to showcase the best innovations of the country and to extend a veritable platform of global exposure to the budding Indian start-up community.
Speaking on the proud occasion, Sunil Maddikatla, Founder & CEO of BlueSemi, said, “We are indeed honored and privileged for having the opportunity to represent India. It fills us with an immense delight and jubilation to have been selected by the Government of India as one of the very few companies who will exhibit their flagship products at the Indian Pavilion at VivaTech. It is a perfect moment for us as our key offering EYVA will have its first European debut before the visiting audience. We are confident that the launch will invoke a stupendous reception with audiences around the world.”